Literature DB >> 12228817

Large epidemic of adenovirus type 4 infection among military trainees: epidemiological, clinical, and laboratory studies.

Shellie A Kolavic-Gray1, Leonard N Binn, Jose L Sanchez, Steven B Cersovsky, Christina S Polyak, Felicia Mitchell-Raymundo, Ludmila V Asher, David W Vaughn, Brian H Feighner, Bruce L Innis.   

Abstract

Outbreaks of adenovirus type 4 (Ad4) acute respiratory disease (ARD) have reemerged among US military personnel during the past decade. A prospective epidemiological investigation of 678 military recruits was conducted at Fort Jackson, South Carolina, in the fall of 1998; 115 (17%) of the recruits were hospitalized for febrile ARD. Adenovirus types 4, 3, and 21 were recovered from the cultures of 70 (72%), 7 (7%), and 2 (2%) of 97 recruits, respectively. In addition, 69 (83%) of the 83 hospitalized and 82 (49%) of the 166 nonhospitalized unit contacts had seroconversion to Ad4, which indicates the very high susceptibility and communicability of Ad4 among military recruits. Young age (<20 years) and male sex increased the risk for anti-Ad4 seroconversion. Recruits from tropical areas had higher preexisting immunity than did recruits from temperate regions. Military recruits are highly susceptible to Ad4 infections. Prompt reinstitution of an adenovirus vaccination program in this high-risk population is urgently needed.

Entities:  

Mesh:

Year:  2002        PMID: 12228817     DOI: 10.1086/342573

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  51 in total

1.  Adenovirus transmission--worthy of our attention.

Authors:  Gregory C Gray
Journal:  J Infect Dis       Date:  2006-08-25       Impact factor: 5.226

2.  Adenoviral gene transfer in bovine adrenomedullary and murine pheochromocytoma cells: potential clinical and therapeutic relevance.

Authors:  Salvatore Alesci; Shiromi M Perera; Edwin W Lai; Christina Kukura; Mones Abu-Asab; Maria Tsokos; John C Morris; Karel Pacak
Journal:  Endocrinology       Date:  2007-05-24       Impact factor: 4.736

3.  Broad-spectrum respiratory tract pathogen identification using resequencing DNA microarrays.

Authors:  Baochuan Lin; Zheng Wang; Gary J Vora; Jennifer A Thornton; Joel M Schnur; Dzung C Thach; Kate M Blaney; Adam G Ligler; Anthony P Malanoski; Jose Santiago; Elizabeth A Walter; Brian K Agan; David Metzgar; Donald Seto; Luke T Daum; Russell Kruzelock; Robb K Rowley; Eric H Hanson; Clark Tibbetts; David A Stenger
Journal:  Genome Res       Date:  2006-02-15       Impact factor: 9.043

4.  Evaluation of PCR testing of ethanol-fixed nasal swab specimens as an augmented surveillance strategy for influenza virus and adenovirus identification.

Authors:  A E Krafft; K L Russell; A W Hawksworth; S McCall; M Irvine; L T Daum; J L Connoly; A H Reid; J C Gaydos; J K Taubenberger
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

5.  Quantitative real-time PCR assay panel for detection and type-specific identification of epidemic respiratory human adenoviruses.

Authors:  Xiaoyan Lu; Elizabeth Trujillo-Lopez; Lisa Lott; Dean D Erdman
Journal:  J Clin Microbiol       Date:  2013-01-16       Impact factor: 5.948

Review 6.  Adenoviruses in immunocompromised hosts.

Authors:  Marcela Echavarría
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

7.  Use of oligonucleotide microarrays for rapid detection and serotyping of acute respiratory disease-associated adenoviruses.

Authors:  Baochuan Lin; Gary J Vora; Dzung Thach; Elizabeth Walter; David Metzgar; Clark Tibbetts; David A Stenger
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

8.  Quantitative detection of human adenoviruses in wastewater and combined sewer overflows influencing a Michigan river.

Authors:  Theng-Theng Fong; Mantha S Phanikumar; Irene Xagoraraki; Joan B Rose
Journal:  Appl Environ Microbiol       Date:  2009-11-30       Impact factor: 4.792

9.  Vaccine-preventable adenoviral respiratory illness in US military recruits, 1999-2004.

Authors:  Kevin L Russell; Anthony W Hawksworth; Margaret A K Ryan; Jennifer Strickler; Marina Irvine; Christian J Hansen; Gregory C Gray; Joel C Gaydos
Journal:  Vaccine       Date:  2006-01-24       Impact factor: 3.641

10.  Neutralizing antibody blocks adenovirus infection by arresting microtubule-dependent cytoplasmic transport.

Authors:  Jason G Smith; Aurelia Cassany; Larry Gerace; Robert Ralston; Glen R Nemerow
Journal:  J Virol       Date:  2008-04-30       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.